IHS National Pharmacy & Therapeutics Committee
National Core Formulary
Last Updated: 03/15/2024
**Note: Medications in GREY indicate removed items.**
 
Generic Medication Name Pharmacological Category (up-to-date) Formulary Brief (if available) Notes / Miscellaneous Similar NCF Medications Active?
Acetaminophen Analgesic, Miscellaneous Short-Acting Opioids (2014) Yes
Adalimumab-bwwd (Hadlima™) Antirheumatic, Disease Modifying; Tumor Necrosis Factor (TNF) Blocking Agent NPTC Update (Jan 2024) Etanercept Yes
Albuterol nebulized solution Beta2 Agonist Asthma & COPD Guidelines Review (2019) Yes
Albuterol, metered dose inhaler (MDI) Beta2 Agonist Asthma & COPD Guidelines Review (2019) *Any product* Yes
Alendronate Bisphosphonate Derivative Osteoporosis (2016) Yes
Allopurinol Antigout Agent; Xanthine Oxidase Inhibitor Gout (2016) Yes
Alogliptin Antidiabetic Agent, Dipeptidyl Peptidase 4 (DPP-4) Inhibitor DPP-IV Inhibitors (2019) Yes
Amitriptyline Antidepressant, Tricyclic Bipolar Disorder (2022) Nortriptyline Yes
Amlodipine Antihypertensive; Calcium Channel Blocker, Dihydropyridine Hypertension (2022) Diltiazem Yes
Amoxicillin Antibiotic, Penicillin Outpatient Abx Stewardship & URIs (2021) Pediatric and Adult oral formulations Amoxicillin and Clavulanate; Penicillin G benzathine; Penicllin V potassium Yes
Amoxicillin and Clavulanate Antibiotic, Penicillin Outpatient Abx Stewardship & URIs (2021) Pediatric and Adult oral formulations Amoxicillin; Penicillin G benzathine; Penicllin V potassium Yes
Anastrozole Antineoplastic Agent, Aromatase Inhibitor NPTC Update Spring 2021 Yes
Angiotensin receptor blocker ===REMOVED from NCF=== (see Losartan) Angiotensin II Receptor Antagonists (2014) Removed April 2012 Losartan No
Apixaban Anticoagulant; Direct Oral Anticoagulant (DOAC); Factor Xa Inhibitor Direct Oral Anticoagulants (2017) Warfarin Yes
Aripiprazole lauroxil Antipsychotic, Atypical (Second Generation) - Injectable Long-Acting Injectable Antipsychotics (2020) Injectable Haloperidol decanoate Yes
Artificial Tear substitute, ophthalmic (preservative free) Ophthalmic Agent, Miscellaneous Ocular Treatments (2022) *Any Preservative-Free product* Ciprofloxacin, Ophthalmic Solution; Corticosteroid (Ophthalmic) - Low Potency; Polymyxin B/trimethoprim, Ophthalmic Solution Yes
Aspirin Antiplatelet Agent; Nonsteroidal Anti-Inflammatory Drug; Salicylate Pregnancy & Prenatal Care (2021) Yes
Atenolol Antihypertensive; Beta-Blocker, Beta1 Selective Hypertension (2022) Propranolol Yes
Atomoxetine Norepinephrine Reuptake Inhibitor, Selective ADHD (Jan 2020) Dextroamphetamine / Amphetamine (immediate release); Dextroamphetamine / Amphetamine (long-acting); Methylphenidate (immediate release); Methylphenidate (long-acting) Yes
Atorvastatin Antilipemic Agent, HMG-CoA Reductase Inhibitor Hyperlipidemia (2022) Pravastatin; Rosuvastatin; Simvastatin Yes
Atypical antipsychotic Antipsychotic, Atypical Bipolar Disorders (2022) *Any product* Aripiprazole lauroxil; Haloperidol decanoate Yes
Azathioprine -OR- Mercaptopurine Immunosuppresant Agent Inflammatory Bowel Disease (2023) Methotrexate; Sulfasalazine Yes
Azithromycin Antibiotic, Macrolide STIs - PART 1 (2021) Yes
Benzoyl Peroxide Topical Skin Product, Acne Acne Treatment (2020) Benzoyl Peroxide AND Clindamycin, topical combination Yes
Benzoyl Peroxide AND Clindamycin, topical combination Topical Skin Product, Acne; Topical Skin Product, Acne (Lincosamide Antibiotic) Acne Treatment (2020) Benzoyl Peroxide Yes
Beta-3 agonist, Any Beta3 Agonist Urinary Incontinence (2023) Either mirabegron -or- vibegron Oxybutynin, extended-release; Oxybutynin, immediate-release Yes
Bictegravir/Emtricitabine/Tenofovir alafenamide Antiretroviral, Integrase Inhibitor (Anti-HIV) HIV Treatment (2019) Dolutegravir/abacavir/lamivudine; Emtricitabine/tenofovir disoproxil fumarate; Raltegravir Yes
Bismuth subsalicylate Antidiarrheal Helicobacter pylori Treatment (2023) Loperamide Yes
Bumetanide -OR- Torsemide Antihypertensive Heart Failure with Preserved Ejection Fraction (HFpEF) (2022) Furosemide; Torsemide -OR- Bumetanide Yes
Buprenorphine, long-acting (**REMS drug**) Analgesic, Opioid; Analgesic, Opioid Partial Agonist MAT for OUD (2021) Any formulation; Restricted to treatment of Opioid Use Disorder; **See REMS here** Buprenorphine, short-acting (**REMS drug**); Buprenorphine-Naloxone (**REMS drug**) Yes
Buprenorphine, short-acting (**REMS drug**) Analgesic, Opioid; Analgesic, Opioid Partial Agonist MAT for OUD (2021) Any formulation; Restricted to treatment of Opioid Use Disorder; **See REMS here** Buprenorphine, long-acting (**REMS drug**); Buprenorphine-Naloxone (**REMS drug**) Yes
Buprenorphine-Naloxone (**REMS drug**) Analgesic, Opioid; Analgesic, Opioid Partial Agonist MAT for OUD (2021) **See REMS here** Naloxone Yes
Bupropion Antidepressant, Dopamine/Norepinephrine-Reuptake Inhibitor; Smoking Cessation Aid Stimulant Use Disorder (2022) Varenicline; Venlafaxine Yes
Calcium Electrolyte Supplement Osteoporosis (2016) *Any formulation* Yes
Carbamazepine Anticonvulsant, Miscellaneous Bipolar Disorder (2022) Divalproex; Lamotrigine; Levetiracetam; Phenytoin; Topiramate Yes
Carbidopa-Levodopa, immediate-release Anti-Parkinson Agent; Decarboxylase Inhibitor-Dopamine Precursor Parkinson's Disease (2019) Yes
Carvedilol, immediate-release Antihypertensive; Beta-Blocker with Alpha-Blocking Activity Heart Failure with Reduced Ejection Fraction (HFrEF) (2022) Atenolol; Propranolol Yes
Cefdinir Antibiotic, Cephalosporin (Third Generation) Outpatient Abx Stewardship & URIs (2021) Pediatric and Adult oral formulations Cefixime; Ceftriaxone Injection; Cephalexin Yes
Cefixime Antibiotic, Cephalosporin (Third Generation) STIs - PART 1 (2021) For outpatient treatment of gonorrhea for Expedited Partner Therapy or when injection therapy is not possible Cefdinir; Ceftriaxone Injection; Cephalexin Yes
Ceftriaxone, injection Antibiotic, Cephalosporin (Third Generation) STIs - PART 1 (2021) Cefdinir; Cefixime; Cephalexin Yes
Cephalexin Antibiotic, Cephalosporin (First Generation) Outpatient Abx Stewardship & URIs (2021) Pediatric and Adult oral formulations Cefdinir; Cefixime; Ceftriaxone Injection Yes
Chlorthalidone Antihypertensive; Thiazide-Related Diuretic Hypertension (2022) Hydrochlorothiazide Yes
Ciprofloxacin, ophthalmic solution Antibiotic, Ophthalmic Fluoroquinolone Ocular Treatments (2022) Artificial Tear substitute, ophthalmic (preservative free); Corticosteroid (Ophthalmic) - Low Potency; Polymyxin B/trimethoprim, Ophthalmic Solution Yes
Ciprofloxacin, oral Antibiotic, Fluoroquinolone Male Genitourinary Infections (Nov 2022) Yes
Citalopram Antidepressant, Selective Serotonin Reuptake Inhibitor Bipolar Disorder (2022) Escitalopram; Fluoxetine; Paroxetine; Sertraline Yes
Clindamycin Antibiotic, Lincosamide Outpatient Abx Stewardship & URIs (2021) Pediatric and Adult oral formulations Yes
Clindamycin, topical ===REMOVED from NCF=== (See Benzoyl Peroxide AND Clindamycin, topical combination) Removed January 2020 No
Clonazepam Benzodiazepine Antiseizure Drugs (2021) Lorazepam Yes
Clopidogrel Antiplatelet Agent Antiplatelets (2015) Aspirin Yes
Clotrimazole, topical Antifungal Agent, Imidazole Derivative Male Genitourinary Infections (Nov 2022) Yes
Conjugated estrogen vaginal cream, (Premarin) ===REMOVED from NCF=== (see Estrogen vaginal cream) NPTC Meeting Update (May 2018) Removed May 2018 Estrogen vaginal cream No
Corticosteroid (Ophthalmic) - Low Potency Corticosteroid, Ophthalmic Ocular Treatments (2022) *Any product - see Form Brief for suggested products Artificial Tear substitute, Ophthalmic (Preservative Free); Ciprofloxacin, Ophthalmic Solution; Polymyxin B/trimethoprim, Ophthalmic Solution; Prednisolone, Ophthalmic Suspension Yes
Corticosteroid (Topical) - Intermediate Potency Topical Corticosteroids Atopic Dermatitis (2020) *Any product* Corticosteroid (Topical) - Low Potency Yes
Corticosteroid (Topical) - Low Potency Topical Corticosteroids Atopic Dermatitis (2020) *Any product* Corticosteroid (Topical) - Intermediate Potency Yes
Corticosteroid, intranasal Intranasal Corticosteroid Allergic Rhinitis (2018) *Any product* Yes
Corticosteroids (Topical) - High Potency (Class I and II) Topical Corticosteroids Alopecia Areata (2022) Corticosteroid (Topical) - Intermediate Potency; Corticosteroid (Topical) - Low Potency Yes
Cyanocobalamin (Vitamin B12), oral Vitamin, Water Soluble Hematologic Supplements (2016) Yes
Dedicated emergency contraceptive ===REMOVED from NCF=== Contraception (2016) Removed Sept 2013 Levonorgestrel (Plan B One-Step®); Ulipristal No
Dextroamphetamine / Amphetamine (immediate release) Central Nervous System Stimulant ADHD (Jan 2020) Pediatric use only Yes
Dextroamphetamine / Amphetamine (long-acting) Central Nervous System Stimulant ADHD (Jan 2020) Pediatric use only Yes
Diclofenac Nonsteroidal Anti-Inflammatory Drug NSAIDs (2014) *Any formulation* Ibuprofen; Indomethacin; Meloxicam; Naproxen Yes
Dicyclomine Anticholinergic Agent Irritable Bowel Syndrome (2018) Yes
Digoxin Antiarrhythmic Agent, Miscellaneous; Cardiac Glycoside Heart Failure with Reduced Ejection Fraction (HFrEF) (2022) Yes
Diltiazem Antihypertensive; Calcium Channel Blocker, Nondihydropyridine Hypertension (2022) Amlodipine Yes
Divalproex Anticonvulsant, Miscellaneous Bipolar Disorder (2022) Carbamazepine; Lamotrigine; Levetiracetam; Phenytoin; Topiramate Yes
Dolutegravir Antiretroviral, Integrase Inhibitor (Anti-HIV) HIV Updates (2020) For HIV treatment in pregnant patients Emtricitabine/tenofovir disoproxil fumarate; Raltegravir Yes
Dolutegravir/Abacavir/Lamivudine Antiretroviral, Integrase Inhibitor (Anti-HIV) HIV Treatment (2019) *Note: HLA B5701 testing required prior to initiation Bictegravir/Emtricitabine/Tenofovir alafenamide; Dolutegravir; Emtricitabine/tenofovir disoproxil fumarate; Raltegravir Yes
Donepezil Acetylcholinesterase Inhibitor (Central) Alzheimer's disease (2019) 5mg and 10mg strengths Yes
Doxazosin Alpha1 Blocker; Antihypertensive Benign Prostatic Hypertrophy (Nov 2022) Prazosin; Tamsulosin Yes
Doxycycline Antibiotic, Tetracycline STIs - PART 1 (2021) Yes
Dulaglutide ===REMOVED from NCF=== NPTC Meeting Update (2020) Removed Nov 2020 No
Duloxetine Antidepressant, Serotonin/Norepinephrine Reuptake Inhibitor/Antagonist Bipolar Disorder (2022) Bupropion; Venlafaxine Yes
Empagliflozin Antidiabetic Agent, Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Heart Failure with Reduced Ejection Fraction (HFrEF) (2022) Yes
Emtricitabine/Tenofovir disoproxil fumarate Antiretroviral, Reverse Transcriptase Inhibitor, Nucleoside (Anti-HIV); Antiretroviral, Reverse Transcriptase Inhibitor, Nucleotide (Anti-HIV) HIV Pre-Exposure Prophylaxis (PrEP) (2018) For (1) Pre-Exposure HIV Prophylaxis, (2) Post-Exposure HIV Prophylaxis (with raltegravir) or (3) HIV Treatment (with raltegravir) in patients with contraindications for 1st line anti-HIV agents Raltegravir Yes
Epinephrine Injection Devices (both 0.15mg and 0.3mg) Alpha-/Beta- Agonist Epinephrine Injection Devices (2020 Any device, auto-injector or pre-filled syringe Yes
Escitalopram Antidepressant, Selective Serotonin Reuptake Inhibitor Bipolar Disorder (2022) Citalopram; Fluoxetine; Paroxetine; Sertraline Yes
Estradiol for Injection Estrogen Derivative Gender Affirming Therapies (2022) Either valerate or cypionate product Estradiol tablets; Estradiol, transdermal Yes
Estradiol tablets Estrogen Derivative Gender-Affirming Medications (2022) Estradiol for Injection; Estradiol, transdermal Yes
Estradiol, transdermal Estrogen Derivative Gender Affirming Therapies (2022) *Any patch* Estradiol for Injection; Estradiol tablets Yes
Estrogen vaginal cream Estrogen Derivative NPTC Meeting Update (May 2018) *Any product* Estradiol tablets Yes
Etanercept Antirheumatic, Disease Modifying; Tumor Necrosis Factor (TNF) Blocking Agent TNF Inhibitors (2016) Adalimumab-bwwd (Hadlima™) Yes
Ethambutol Antitubercular Agent Treatment of Tuberculosis (2021) Isoniazid; Pyrazinamide; Rifampin; Rifapentine Yes
Ethinyl estradiol / Etonogestrel vaginal ring Contraceptive; Estrogen and Progestin Combination Contraception (2016) Yes
Ethinyl estradiol / Norelgestromin, transdermal Contraceptive; Estrogen and Progestin Combination Contraception (2016) Yes
Ethosuximide Anticonvulsant, Succinimide Anti-Seizure Drugs (2021) Carbamazepine; Clonazepam; Divalproex; Gabapentin; Lamotrigine; Levetiracetam; Phenytoin; Topiramate Yes
Etonogestrel, implant Contraceptive; Progestin Long Acting Reversible Contraception (2021) For use by a skilled and privileged provider Oral contraceptive pill, progestin only Yes
Ezetimibe Antilipemic Agent, 2-Azetidinone Hyperlipidemia (2022) Yes
Famotidine Histamine H2 Antagonist Fall 2022 NPTC Meeting Update Yes
Fibric Acid Derivative ===REMOVED from NCF=== Hyperlipidemia (2017) Removed Feb 2017 No
Finasteride 5 Alpha-Reductase Inhibitor Benign Prostatic Hypertrophy (Nov 2022) Yes
Fluconazole, oral Antifungal Agent, Azole Derivative Male Genitourinary Infections (Nov 2022) Yes
Fluoride, oral Nutritional Supplement Supplements in Oral Health (2016) *Any oral formulation* Yes
Fluoxetine Antidepressant, Selective Serotonin Reuptake Inhibitor Bipolar Disorder (2022) Sertraline Yes
Fluticasone / Salmeterol (Advair®) Removed Oct 2012 Fluticasone/salmeterol No
Fluticasone/Salmeterol Beta2 Agonist, Long-Acting; Corticosteroid, Inhalant LABAs (2019) Mometasone (Asmanex®) Yes
Folic Acid Vitamin, Water Soluble Pregnancy & Prenatal Care (2021) Any product containing >400 mcg / daily dose Yes
Furosemide Antihypertensive Heart Failure with Preserved Ejection Fraction (HFpEF) (2022) Yes
Gabapentin Anticonvulsant, Miscellaneous; GABA Analog Antiseizure Drugs (2021) Yes
Gemfibrozil ===REMOVED from NCF=== Dyslipidemia Guidelines Review (2014) Removed Feb 2014 No
Glecaprevir/Pibrentasvir (Mavyret®) Antihepaciviral HCV Treatment (2018) Ledipasvir/sofosbuvir (Harvoni®); Sofosbuvir/velpatasvir (Epclusa®) Yes
Glipizide Antidiabetic Agent; Sulfonylurea Diabetes Treatment Overview (2017) Yes
Glucagon Antidote; Hypoglycemia Glucagon Products Review (2021) For outpatient use Yes
Glucose, oral Antidote Glucagon Products Review (2021) Any formulation Glucagon Yes
Glyburide ===REMOVED from NCF=== (see Glipizide) Sulfonylureas (2015) Removed May 2015 Glipizide No
H1 Antagonist (2nd generation), long-acting Histamine H1 Antagonist, Second Generation Allergic Rhinitis (2018) *Any product* Yes
Haloperidol decanoate Antipsychotic, Typical (First Generation) - Injectable Long-Acting Injectable Antipsychotics (2020) Injectable Aripiprazole lauroxil Yes
Hydrochlorothiazide Antihypertensive; Thiazide Diuretic Hypertension (2022) Chlorthalidone Yes
Hydroxychloroquine Antimalarial Non-biologic DMARDs (2016) Leflunomide; Methotrexate; Sulfasalazine Yes
Hydroxyzine Histamine H1 Antagonist, First Generation Anxiety Disorders (2021) Yes
Ibuprofen Nonsteroidal Anti-Inflammatory Drug NSAIDs (2014) Diclofenac; Indomethacin; Meloxicam; Naproxen Yes
Imipramine ===REMOVED from NCF=== (see Nortriptyline) Antidepressant Use in Chronic Pain (2014) Removed May 2014 Nortriptyline No
Indomethacin Nonsteroidal Anti-Inflammatory Drug NSAIDs (2014) Diclofenac; Ibuprofen; Meloxicam; Naproxen Yes
Insulin aspart (NovoLog®) Insulin, Rapid-Acting Diabetes Treatment Overview (2017) *Branded product*; Pen Device Yes
Insulin aspart / Insulin aspart protamine (NovoLog® Mix 70/30) Insulin, Combination (70/30 Mix) Diabetes Treatment Overview (2017) *Branded product*; Pen Device Yes
Insulin detemir (Levemir®) ===REMOVED from NCF=== Removed October 2023 No
Insulin glargine (Lantus®) ===REMOVED from NCF=== (see Insulin detemir) NPTC Meeting Update (May 2019) Removed May 2019 Insulin detemir (Levemir®) No
Insulin glargine, Any Insulin, Long-Acting Long-Acting Insulins & Biosimilars (2021) *Biosimilars of insulin glargine are intended to be included for consideration Yes
Insulin NPH (NovoLIN® N) Insulin, Intermediate-Acting Diabetes Treatment Overview (2017) *Branded product* Yes
Insulin NPH / Regular human insulin (NovoLIN® 70/30) Insulin, Combination (70/30 Mix) Diabetes Treatment Overview (2017) *Branded product* Yes
Insulin Regular human (NovoLIN® R) Insulin, Short-Acting Diabetes Treatment Overview (2017) *Branded product* Yes
Intrauterine device, copper Contraceptive Long Acting Reversible Contraception (2021) *Any product*; For use by a skilled and privileged provider Intrauterine device, levonorgestrel Yes
Intrauterine device, levonorgestrel Contraceptive, Progestin Long Acting Reversible Contraception (2021) *Any product*; For use by a skilled and privileged provider Intrauterine device, copper Yes
Ipratropium, MDI ===REMOVED from NCF=== COPD Inhalers (2015) Removed Aug 2015 Albuterol, metered dose inhaler (MDI); Tiotropium (Spiriva®) No
Iron, oral Iron Salt Pregnancy & Prenatal Care (2021) *Any oral formulation* Yes
Isoniazid Antitubercular Agent Treatment of Tuberculosis (2021) Ethambutol; Pyrazinamide; Rifampin; Rifapentine Yes
Isosorbide dinitrate ===REMOVED from NCF=== (see Isosorbide mononitrate) Removed Aug 2013 Isosorbide mononitrate No
Isosorbide mononitrate Antianginal Agent; Vasodilator Anti-Anginal Treatment (2013) Nitroglycerin patch Yes
Lactulose Ammonium Detoxicant; Laxative, Osmotic Hepatic Encephalopathy (2020) Polyethylene glycol Yes
Lamotrigine Anticonvulsant, Miscellaneous Bipolar Disorder (2022) Carbamazepine; Divalproex; Levetiracetam; Phenytoin; Topiramate Yes
Laxative, bulk-forming Bulk-forming Laxative Added July 2011 (Constipation) *Any product* Yes
Laxative, stimulant Stimulant Laxative Added July 2011 (Constipation) *Any product* Yes
Ledipasvir/Sofosbuvir (Harvoni®) Antihepaciviral HCV Treatment (2018) Glecaprevir/Pibrentasvir (Mavyret®); Sofosbuvir/velpatasvir (Epclusa®) Yes
Leflunomide Antirheumatic, Disease Modifying Non-biologic DMARDs (2016) Hydroxychloroquine; Methotrexate; Sulfasalazine Yes
Letrozole Antineoplastic Agent, Aromatase Inhibitor NPTC Update Spring 2021 Yes
Leuprolide Antineoplastic Agent, Gonadotropin-Releasing Hormone Agonist Treatment of Prostate Cancer (Nov 2022) **Any depot form** Yes
Levetiracetam Anticonvulsant, Miscellaneous Antiseizure Drugs (2021) Carbamazepine; Divalproex; Lamotrigine; Phenytoin; Topiramate Yes
Levonorgestrel (Plan B One-Step®) Contraceptive, Progestin Contraception (2016) *Branded product* Ulipristal Yes
Levothyroxine Thyroid Agent Originally added 2004 Yes
Liraglutide -or- Semaglutide ===REMOVED from NCF=== Removed October 2023 No
Lisinopril Antihypertensive, Angiotensin-Converting Enzyme Inhibitor Hypertension (2022) Yes
Lithium Antimanic Agent Bipolar Disorder (2022) Yes
Long-acting monoclonal antibodies, All ACIP-recommended Immune Globulin; Monoclonal Antibody Prevention of RSV (2023) For example: nirsevimab (Beyfortus®) Yes
Loperamide Antidiarrheal Irritable Bowel Syndrome (2018) Yes
Lopinavir / Ritonavir (Kaletra®) ===REMOVED from NCF=== (see Emtricitabine/tenofovir) HIV PrEP (2018) Removed August 2013 No
Lorazepam Benzodiazepine Alcohol Withdrawal Syndrome (2015) Clonazepam Yes
Losartan Antihypertensive, Angiotensin II Receptor Blocker Hypertension (2022) Yes
Lovastatin ===REMOVED from NCF=== Dyslipidemia Guidelines Review (2014) Removed April 2012 Atorvastatin; Pravastatin; Rosuvastatin; Simvastatin No
Low-molecular weight heparin Low-molecular Weight Heparin VTE Prophylaxis (2011) *Any product* Yes
Medroxyprogesterone acetate, injection (IM and SC formulations) Contraceptive, Progestin (Injection/Depot) SC Depot Medroxyprogesterone (2023) Both SC and IM formulations should be made available Medroxyprogesterone, oral Yes
Medroxyprogesterone, oral Contraceptive; Progestin Polycystic Ovarian Syndrome (2017) Medroxyprogesterone acetate, injection; Oral contraceptive pill, progestin only Yes
Meloxicam Nonsteroidal Anti-Inflammatory Drug NSAIDs (2014) Diclofenac; Ibuprofen; Indomethacin; Naproxen Yes
Memantine N-Methyl-D-Aspartate (NMDA) Receptor Antagonist Alzheimer's disease (2019) Yes
Mercaptopurine -OR- Azathioprine Immunosuppresant Agent Inflammatory Bowel Disease (2023) Methotrexate; Sumatriptan Yes
Mesalamine, oral 5-Aminosalicylic Acid Derivative Inflammatory Bowel Disease (2023) Once-Daily Formulation Sulfasalazine Yes
Metformin Antidiabetic Agent; Biguanide Diabetes Treatment Overview (2017) Yes
Methimazole Antithyroid Agent; Thioamide Hyperthyroidism (2021) Propylthiouracil Yes
Methotrexate Antineoplastic Agent; Antirheumatic; Disease Modifying; Immunosuppresant Agent Non-biologic DMARDs (2016) Hydroxychloroquine; Leflunomide; Sulfasalazine Yes
Methylphenidate (immediate release) Central Nervous System Stimulant ADHD (Jan 2020) Pediatric use only Methylphenidate (long-acting) Yes
Methylphenidate (long-acting) Central Nervous System Stimulant ADHD (Jan 2020) Pediatric use only Methylphenidate (immediate release) Yes
Metoprolol succinate Antihypertensive; Beta-Blocker, Beta1 Selective Heart Failure with Reduced Ejection Fraction (HFrEF) (2022) Atenolol; Carvedilol, immediate-release; Propranolol Yes
Metoprolol tartrate Antihypertensive; Beta-Blocker, Beta1 Selective Heart Failure with Reduced Ejection Fraction (HFrEF) (2022) Atenolol; Carvedilol, immediate-release; Metoprolol succinate Yes
Metronidazole, oral Antibiotic, Miscellaneous 2021 CDC Guidelines for Sexually Transmitted Infections (2021) Tinidazole Yes
Metronidazole, topical Antibiotic, Topical Rosacea (2022) Yes
Moisturizers (both cream- AND petroleum-based) Skin and Mucous Membrane Agent, Miscellaneous; Topical Skin Product Atopic Dermatitis (2020) Corticosteriods (Topical) - High potency (Class I and II); Corticosteroid (Topical) - Intermediate potency; Corticosteroid (Topical) - Low potency; Tacrolimus Yes
Mometasone (Asmanex®) Corticosteroid, Inhalant Asthma & COPD Guidelines Review (2019) *Branded product* Yes
Mometasone / Formoterol (Dulera®) ===REMOVED from NCF=== (see Fluticasone/salmeterol) LABAs (2019) Removed June 2019 Fluticasone/salmeterol No
Montelukast Leukotriene Receptor Antagonist Asthma & COPD Guidelines Review (2019) Yes
Mupirocin Antibiotic, Topical Skin & Soft Tissue Infections (2021) Yes
Naloxone Antidote; Opioid Antagonist Opioid Use Disorder (2018) Yes
Naltrexone, extended-release for injection Antidote; Opioid Antagonist Opioid Use Disorder (2018) Yes
Naltrexone, oral Antidote; Opioid Antagonist Alcohol Use Disorder (2022) Naloxone Yes
Naproxen Nonsteroidal Anti-Inflammatory Drug NSAIDs (2014) Diclofenac; Ibuprofen; Indomethacin Yes
Niacin extended release (Niaspan®) ===REMOVED from NCF=== Hyperlipidemia (2017) Removed Feb 2017 No
Nicotine replacement therapy (NRT), combination Smoking Cessation Aid Nicotine Dependence (2020) Combination NRT (nicotine patches + any short-acting NRT product) Bupropion; Varenicline Yes
Nifedipine (controlled or extended release) ===REMOVED from NCF=== Calcium Channel Blockers (2014) Removed August 2014 Amlodipine No
Nirmatrelvir and Ritonavir (Paxlovid®) Antiviral Agent; Cytochrome P-450 Inhibitor COVID-19 Update (2023) Yes
Nitrofurantoin Antibiotic, Miscellaneous Urinary Tract Infections (2021) Yes
Nitroglycerin 0.4 milligrams, sublingual Antianginal Agent; Antidote, Extravasation; Vasodilator Anti-Anginal Treatment (2013) Isosorbide mononitrate; Nitroglycerin patch Yes
Nitroglycerin patch Antianginal Agent; Antidote, Extravasation; Vasodilator Anti-Anginal Treatment (2013) Isosorbide mononitrate Yes
Norgestrel 0.075mg OTC tablets (Opill®) Contraceptive, Progestin Norgestrel OTC - Opill (2023) Oral contraceptive pill, progestin only (prescription) Yes
Nortriptyline Antidepressant, Tricyclic Bipolar Disorder (2022) Amitriptyline Yes
Omeprazole (enteric coated) ===REMOVED from NCF=== (see Proton Pump Inhibitor) Long-Term Use of PPIs (2014) Removed Feb 2014 Proton Pump Inhibitor No
Ondansetron Antiemetic; Selective 5-HT3 Receptor Antagonist Antiemetic Agents (2021) Yes
Ophthalmic Prostaglandin Analog Ophthalmic Prostaglandin Analog Ophth Prostaglandin Analogs (2018) *Any product* Yes
Oral contraceptive pill, extended cycle Contraceptive Contraception (2016) *Any product* Yes
Oral contraceptive pill, monophasic: 20mcg EE (low) Contraceptive Contraception (2016) *Any product* Yes
Oral contraceptive pill, monophasic: 30-35mcg EE (medium) Contraceptive Contraception (2016) *Any product* Yes
Oral contraceptive pill, progestin only (prescription) Contraceptive, Progestin Norgestrel OTC - Opill (2023) *Any product* Yes
Oral contraceptive pill, triphasic Contraceptive Contraception (2016) *Any product* Yes
Oseltamivir Antiviral Agent; Neuraminidase Inhibitor Treatment of Influenza (2019) Yes
Oxcarbazepine Anticonvulsant, Miscellaneous Bipolar Disorder (2022) Carbamazepine; Clonazepam; Divalproex; Gabapentin; Lamotrigine; Levetiracetam; Phenytoin; Topiramate Yes
Oxybutynin, extended-release Antispasmodic Agent, Urinary Antimuscarinics (2019) Oxybutynin, Immediate-release Yes
Oxybutynin, immediate-release Antispasmodic Agent, Urinary Antimuscarinics (2019) Oxybutynin, extended-release Yes
Paroxetine Antidepressant, Selective Serotonin Reuptake Inhibitor Bipolar Disorder (2022) Citalopram; Escitalopram; Fluoxetine; Sertraline Yes
Penicillin G benzathine Antibiotic, Penicillin STIs - PART 1 (2021) Amoxicillin; Amoxicillin and Clavulanate; Penicllin V potassium Yes
Penicillin V potassium Antibiotic, Penicillin Outpatient Abx Stewardship & URIs (2021) Pediatric and Adult oral formulations Amoxicillin; Amoxicillin and Clavulanate; Penicillin G benzathine Yes
Permethrin 1% Antiparasitic Agent, Topical; Pediculocide; Scabicidal Agent Sexually Transmitted Infections, Part III (2022) *Any formulation* Permethrin 5% cream Yes
Permethrin 5% cream Antiparasitic Agent, Topical; Pediculocide; Scabicidal Agent Sexually Transmitted Infections, Part III (2022) Permethrin 1%, any formulation Yes
Phentermine and Topiramate ER (**REMS drug**) ===REMOVED from NCF=== Removed October 2023 No
Phenytoin Anticonvulsant, Hydantoin Antiseizure Drugs (2021) Carbamazepine; Divalproex; Lamotrigine; Levetiracetam; Topiramate Yes
Phosphodiesterase 5 (PDE5) Inhibitor ===REMOVED from NCF=== Erectile Dysfunction (Nov 2022) Removed November 2022 No
Pioglitazone Antidiabetic Agent, Thiazolidinedione Thiazolidinediones (2017) Yes
Polyethylene glycol Laxative, Osmotic Irritable Bowel Syndrome (2018) *Any product* Lactulose Yes
Polymyxin B/Trimethoprim, ophthalmic solution Antibiotic, Ophthalmic Ocular Treatments (2022) Artificial Tear substitute, ophthalmic (preservative free); Ciprofloxacin, ophthalmic solution; Corticosteroid (Ophthalmic) - Low Potency Yes
Pramipexole Anti-Parkinson Agent, Dopamine Agonist Insomnia/Sleep Medications (2021) Yes
Pravastatin Antilipemic Agent, HMG-CoA Reductase Inhibitor Hyperlipidemia (2022) Atorvastatin; Rosuvastatin; Simvastatin Yes
Prazosin Alpha1 Blocker; Antihypertensive Post Traumatic Stress Disorder (2021) Doxazosin; Tamsulosin Yes
Prednisolone acetate, ophthalmic suspension Corticosteroid, Ophthalmic Ocular Treatments (2022) Artificial Tear substitute, ophthalmic (preservative free); Ciprofloxacin, ophthalmic solution; Corticosteroid (Ophthalmic) - Low Potency; Polymyxin B/Trimethoprim, ophthalmic solution Yes
Prednisone Corticosteroid, Systemic Atopic Dermatitis (2020) Yes
Prenatal Multivitamin Vitamin Pregnancy & Prenatal Care (2021) Must contain >400 mcg of folic acid/dose Yes
Propranolol Antihypertensive; Beta-Blocker, Non-Selective Migraine Prevention (2019) Atenolol Yes
Propylthiouracil Antithyroid Agent; Thioamide Hyperthyroidism (2021) Methimazole Yes
Proton Pump Inhibitor Proton Pump Inhibitor GERD & PUD (2018) *Any product* Yes
Pyrazinamide Antitubercular Agent Treatment of Tuberculosis (2021) Ethambutol; Isoniazid; Rifampin Yes
Pyridoxine (Vitamin B6) Vitamin, Water Soluble Pregnancy & Prenatal Care (2021) Yes
Raltegravir Antiretroviral, Integrase Inhibitor (Anti-HIV) HIV Treatment (2019) For (1) HIV Post-Exposure Prophylaxis (with emtricitabine/ tenofovir DF) or (2) HIV Treatment (with emtricitabine/tenofovir DF) in patients with contraindications for 1st line anti-HIV agents Emtricitabine/tenofovir disoproxil fumarate Yes
Ranitidine ===REMOVED from NCF=== Removed August 2022 No
Rifampin Antitubercular Agent Treatment of Tuberculosis (2021) Ethambutol; Isoniazid; Pyrazinamide; Rifapentine Yes
Rifapentine Antitubercular Agent Treatment of Tuberculosis (2021) Ethambutol; Isoniazid; Pyrazinamide; Rifampin Yes
Rifaximin Antibiotic, Rifamycin Hepatic Encephalopathy (2020) After failure of, or intolerance to, lactulose monotherapy as indicated for hepatic encephalopathy Lactulose Yes
Rosuvastatin Antilipemic Agent, HMG-CoA Reductase Inhibitor Hyperlipidemia (2022) Atorvastatin; Pravastatin; Simvastatin Yes
Sacubitril and Valsrtan Angiotensin II Receptor Blocker; Neprilysin Inhibitor Heart Failure with Reduced Ejection Fraction (HFrEF) (2022) Yes
Salmeterol (Serevent®) ===REMOVED from NCF=== Inhaled Anticholinergics (2011) Removed Sept 2011 No
Salsalate Salicylate Added June 2008 (NSAIDs) Yes
Saxagliptin ===REMOVED from NCF=== (see Alogliptin) DPP-IV Inhibitors (2019) Removed Feb 2019 Alogliptin No
Semaglutide (Ozempic®) Antidiabetic Agent, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist GLP-1 & GLP-1/GIP Receptor Agonists for DM2 and Obesity (2023) Subcutaneous formulation only Yes
Semaglutide (Wegovy®) -OR- Tirzepatide (Zepbound™) Antidiabetic Agent, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist; Glucose-Dependent Insulinotropic Polypeptide (GIP)/Glucagon-Like Peptide (GLP-1) Receptor Agonist NPTC Update (Jan 2024) For weight management, with recommended local adoption of use criteria Yes
Semaglutide, dulaglutide or liraglutide ===REMOVED from NCF=== Dulaglutide removed from NCF; liraglutide and semaglutide remain on NCF No
Serotonin 5-HT1 agonist (Triptan) Antimigraine Agent; Serotonin 5-HT 1B/1D Receptor Agonist Acute Migraine (2021) Any two (2) triptan medications are required, one must be sumatriptan Sumatriptan Yes
Sertraline Antidepressant, Selective Serotonin Reuptake Inhibitor Bipolar Disorder (2022) Citalopram; Escitalopram; Fluoxetine; Paroxetine Yes
Sevelamer carbonate Phosphate Binder Phosphate Binders (2018) For patients on dialysis who cannot use calcium-based phosphate binders due to hypercalcemia Calcium Yes
Sildenafil Phosphodiesterase-5 Enzyme Inhibitor Erectile Dysfunction (Nov 2022) Tadalafil Yes
Simvastatin Antilipemic Agent, HMG-CoA Reductase Inhibitor Hyperlipidemia (2022) Atorvastatin; Pravastatin; Rosuvastatin Yes
Sofosbuvir/Velpatasvir (Epclusa®) Antihepaciviral HCV Treatment (2018) Glecaprevir/Pibrentasvir (Mavyret®); Ledipasvir/Sofosbuvir (Harvoni®) Yes
Spironolactone Antihypertensive; Mineralocorticoid Receptor Antagonists; Potassium Sparing Diuretic Heart Failure with Reduced Ejection Fraction (HFrEF) (2022) Yes
Sulfasalazine 5-Aminosalicylic Acid Derivative Inflammatory Bowel Disease (2018) Hydroxychloroquine; Leflunomide; Methotrexate Yes
Sulindac ===REMOVED from NCF=== NSAIDs in Chronic Pain (2014) Removed May 2014 Diclofenac; Ibuprofen; Indomethacin; Meloxicam; Naproxen No
Sumatriptan Antimigraine Agent; Serotonin 5-HT 1B/1D Receptor Agonist Acute Migraine (2021) Any two (2) triptan medications are required, one must be sumatriptan Yes
Sunscreen, Sun Protection Factor (SPF) 30 or greater Ultraviolet light protectant, topical Rosacea Treatment (2022) Yes
Tacrolimus, topical Calcineurin Inhibitor; Immunosuppressant Agent; Topical Skin Product Atopic Dermatitis (2020) Corticosteriods (Topical) - High Potency (Class I and II); Corticosteroid (Topical) - Intermediate Potency; Corticosteroid (Topical) - Low Potency; Moisturizers (both cream- AND petroleum-based) Yes
Tadalafil Phosphodiesterase-5 Enzyme Inhibitor Erectile Dysfunction (Nov 2022) Sildenafil Yes
Tamoxifen Antineoplastic Agent, Estrogen Receptor Antagonist; Selective Estrogen Receptor Modulator NPTC Update Spring 2021 Yes
Tamsulosin Alpha1 Blocker Benign Prostatic Hypertrophy (Nov 2022) Doxazosin; Prazosin Yes
Terazosin ===REMOVED from NCF=== Prazosin in PTSD (2012) Removed Jan 2012 Doxazosin; Prazosin; Tamsulosin No
Testosterone (**REMS Drug**) Androgen Male Hypogonadism (2022) Any formulation; Certain formulations (i.e., undecoanate) have REMS requirements Yes
Tinidazole Antibiotic, Miscellaneous 2021 CDC Guidelines for Sexually Transmitted Infections (2021) Metronidazole Yes
Tiotropium (Spiriva®) Long-Acting Anticholinergic Agent Long Acting Muscarinic Antagonists (2019) *Branded product* Yes
Tirzepatide (Zepbound™) -OR- Semaglutide (Wegovy®) Antidiabetic Agent, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist; Glucose-Dependent Insulinotropic Polypeptide (GIP)/Glucagon-Like Peptide (GLP-1) Receptor Agonist NPTC Update (Jan 2024) For weight management, with recommended local adoption of use criteria Yes
Topiramate Anticonvulsant, Miscellaneous Alcohol Use Disorder (2022) Carbamazepine; Divalproex; Lamotrigine; Levetiracetam; Phenytoin Yes
Torsemide -OR- Bumetanide Antihypertensive Heart Failure with Preserved Ejection Fraction (HFpEF) (2022) Bumetanide -OR- Torsemide; Furosemide Yes
Trazodone ===REMOVED from NCF=== Insomnia (2015) Removed Oct 2015 No
Tretinoin, topical Topical Skin Product, Acne Treatment of Acne vulgaris (2020) *Any product* Yes
Trimethoprim-Sulfamethoxazole Antibiotic, Miscellaneous Skin & Soft Tissue Infections (2021) Yes
Trospium ===REMOVED from NCF=== (see Oxybutynin ER, IR) Antimuscarinics (2019) Removed Feb 2019 Oxybutynin, Extended-release; Oxybutynin, Immediate-release No
Ulipristal Contraceptive; Progestin Receptor Modulator Contraception (2016) Levonorgestrel (Plan B One-Step®) Yes
Umeclidinium/Vilanterol Long-Acting Muscarinic Antagonist (LAMA) / Long-Acting Beta2 Agonist (LABA) LAMAs (2019) Tiotropium (Spiriva®) Yes
Vaccines, All ACIP-recommended Vaccines Vaccine (2011) All ACIP recommended vaccines for routine use in accordance with ACIP guidelines Yes
Valacyclovir Antiviral Agent, Oral 2021 CDC Guidelines for Sexually Transmitted Infections (2021) Yes
Vancomycin, oral Glycopeptide Clostridioides Difficile (2023) Metronidazole, oral Yes
Varenicline Partial Nicotine Agonist, Smoking Cessation Aid Nicotine Dependence (2020) Bupropion Yes
Venlafaxine Antidepressant, Serotonin/Norepinephrine Reuptake Inhibitor/Antagonist Bipolar Disorder (2022) Bupropion; Duloxetine Yes
Verapamil ===REMOVED from NCF=== (see Diltiazem) Calcium Channel Blockers (2014) Removed August 2014 Diltiazem No
Vitamin D Analog, topical Vitamin D Analog Psoriasis (2018) *Any product* Yes
Vitamin D, Any Vitamin D Analog Vitamin D Analogues in CKD (2010) *Any product* Yes
Warfarin Anticoagulant; Vitamin K Antagonist Direct Oral Anticoagulants (2017) Apixaban; Low-molecular weight heparin Yes